| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |